Motley Fool Money
LiSTNR
This podcast gives you a smart, cool headed and down to earth wrap on the latest finance and investing news from Australia & around the world. Investing legends Scott Phillips and Andrew Page walk you through what’s really going on and what you need to know to make great financial decisions. Subscribe to get your regular fix of BS-free money advice. Sign up for the newsletter at fool.com.au/LiSTNR
For more episodes download the free LiSTNR app
For more episodes download the free LiSTNR app
Episodes
Mentioned books
Dec 1, 2021 • 2min
Stock of the Week Episode SNAFU
Unfortunately, operator error means this week's episode isn't available via podcast. Sorry Fools!See omnystudio.com/listener for privacy information.
Nov 28, 2021 • 1h 6min
Mailbag Extra: incl. Why not just buy an ETF and avoid the risk? November 28, 2021
-- A little bit of positive feedback -- Why aren't my favourite ETFs available in my Super fund? -- Why are you guys giving stuff away for free? -- Can I just buy an ETF and avoid the risk? -- How can I get a job in the investing world? -- What crypto app should I use?See omnystudio.com/listener for privacy information.
Nov 26, 2021 • 1h 11min
A super-investor's warning for ‘defensive’ investors. November 26, 2021
--The bond market says rates will go up 1.4% by April 2023! -- The end of the housing boom? -- $4 billion for Black Friday -- A super-investor's warning for ‘defensive’ investorsSee omnystudio.com/listener for privacy information.
Nov 24, 2021 • 23min
Stock of the Week: Nanosonics (ASX:NAN), November 24, 2021
Andrew Leggett, a Motley Fool analyst covering healthcare and med-tech, discusses Nanosonics and its Trophon high-level disinfection system. He explains how the device cleans ultrasound probes and why probe sterilisation matters for preventing hospital infections. Conversation covers Trophon adoption, the razor-and-blade consumables model, pandemic effects on sales, market position and competition, and regulatory and concentration risks.
Nov 21, 2021 • 1h 10min
Mailbag Extra: incl. Are insider transactions good signals? November 21, 2021
-- How do execs and directors avoid insider trading? -- Are insider transactions good signals? -- What's happening to PolyNovo and Volpara? -- How do you find out the fair value of a fund? -- Will Web 3.0 kill the big tech companies? -- I'm young, and own 30 companies. How do I manage from here?See omnystudio.com/listener for privacy information.
Nov 19, 2021 • 1h 1min
ETFs ain't ETFs. November 19, 2021
-- What? Scott bought Fortescue? -- Rates, inflation and wages. We're not in Kansas any more, Toto -- CBA's 20% growth disappoints investors -- Don't pay twice for quality -- ETFs ain't ETFsSee omnystudio.com/listener for privacy information.
Nov 17, 2021 • 20min
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.
Nov 14, 2021 • 1h 11min
Mailbag Extra: incl. What we'd buy if the market tanked. November 14, 2021
-- How can I find out what stocks my ETFs hold? -- Does it matter what I value a company for, if the market disagrees? -- What would we buy if the market tanked 20%? -- How should I factor currency movements into my overseas share portfolio? -- Where can I find 'short selling' stats... and should I care? -- Isn't Ram's Bitcoin thesis busted? -- What about Bitcoin's market-cap?See omnystudio.com/listener for privacy information.
Nov 12, 2021 • 1h 10min
Why efficiency is the enemy of long term success. November 12, 2021
-- Pushpay falls off a cliff... value or value trap? -- How to think about -- and value -- companies at different lifestages -- Efficiency is the enemy of long term success -- A new EV-maker... with a $140b market capSee omnystudio.com/listener for privacy information.
Nov 10, 2021 • 23min
Stock of the Week: Electro Optic Systems (ASX:EOS), November 10, 2021
Scott is joined by Motley Fool analyst Andrew Legget to talk about space and defence contractor Electro Optic Systems (ASX:EOS): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.
